This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI PI-3 KINASE p85 SUBUNIT ALPHA
catalog :
MCA1168
quantity :
2 ml
price :
414 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
U13
reactivity :
human, mouse, rat, bovine
application :
western blot, immunoprecipitation
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA1168
Description :
MOUSE ANTI PI-3 KINASE p85 SUBUNIT ALPHA
Specificity :
PI-3 KINASE p85 SUBUNIT ALPHA
TargetSpecies :
Bovine
Host :
Mouse
Format :
S/N
Isotypes :
IgG1
Applications :
WB,IP
ApplicationTypes :
Western Blotting,Immunoprecipitation
CrossReactivities :
Human,Mouse,Monkey,Rat
Clone :
U13
Quantity :
2 ml
QuantityValue :
2
QuantityType :
ml
GOAccessions :
GO:0070848,GO:0051591,GO:0051219,GO:0051117,GO:0048662,GO:0048009,GO:0045861,GO:0045776,GO:0045768,GO:0045663,GO:0045471,GO:0043560,GO:0043551,GO:0043548,GO:0043200,GO:0033574,GO:0032570,GO:0032355,GO:0031625,GO:0030335,GO:0030331,GO:0022408,GO:0019904,GO:0019901,GO:0019717,GO:0046935,GO:0016303,GO:0010628,GO:0010459,GO:0010040,GO:0009750,GO:0042493,GO:0008286,GO:0008022,GO:0007584,GO:0030971,GO:0006006,GO:0005943,GO:0005634,GO:0005625,GO:0005516,GO:0005161,GO:0005159,GO:0005158,GO:0043125,GO:0001934,GO:0001878,GO:0005886,GO:0048009,GO:0045671,GO:0043560,GO:0043066,GO:0035014,GO:0030335,GO:0030183,GO:0016303,GO:0008286,GO:0006468,GO:0005943,GO:0005159,GO:0005158,GO:0043125,GO:0001953,GO:0090004,GO:0014065,GO:0046326,GO:0019903,GO:0048015,GO:0030168,GO:0031295,GO:0035014,GO:0043559,GO:0043560,GO:0044419,GO:0046854,GO:0048009,GO:0048011,GO:0050852,GO:0050900,GO:0060396,GO:0090004,GO:0046854,GO:0048009,GO:0008286,GO:0046326,GO:0035014,GO:0043560,GO:0005158,GO:0043125,GO:0005159,GO:0005943,GO:0043125,GO:0005158,GO:0005159,GO:0005545,GO:0005943,GO:0007173,GO:0008286,GO:0008543,GO:0071548,GO:0071445,GO:0071398
GOTerms :
bacterial inner membrane,cell membrane,cytoplasmic membrane,GO:0005904,inner endospore membrane,juxtamembrane,plasma membrane lipid bilayer,plasmalemma,activation of protein amino acid phosphorylation,positive regulation of protein amino acid phosphorylation,stimulation of protein amino acid phosphorylation,up regulation of protein amino acid phosphorylation,upregulation of protein amino acid phosphorylation,up-regulation of protein amino acid phosphorylation,HER3 receptor binding,Neu/ErbB-2 receptor activity,insulin receptor ligand,GO:0005067,IGF receptor binding,insulin-like growth factor,insulin-like growth factor receptor ligand,PDGF,PDGF receptor binding,PDGFR binding,platelet-derived growth factor,platelet-derived growth factor receptor ligand,soluble,cell nucleus,1-phosphatidylinositol-4-phosphate kinase, class IA complex,class IA PI3K complex,GO:0035030,phosphoinositide 3-kinase complex, class IA,cellular glucose metabolic process,glucose metabolism,transmembrane receptor protein tyrosine kinase ligand binding,nutritional response pathway,response to nutrients,carboxylate-terminal binding,carboxylate-terminus binding,carboxyl-terminal binding,carboxyl-terminus binding,carboxy-terminal binding,carboxy-terminus binding,COOH-terminal binding,COOH-terminus binding,C-terminal binding,C-terminal end binding,daf-2 receptor signaling pathway,insulin receptor signalling pathway,drug resistance,drug susceptibility/resistance,GO:0017035,response to iron(II),1-phosphatidylinositol 3-kinase activity,ATP:1-phosphatidyl-1D-myo-inositol 3-phosphotransferase activity,GO:0004429,phosphatidylinositol 3-kinase activity, class I,phosphatidylinositol 3-kinase activity, class II,phosphatidylinositol 3-kinase activity, class III,phosphatidylinositol 3-kinase, class I, catalyst activity,PI3K,PI3-kinase activity,PtdIns-3-kinase activity,type I phosphatidylinositol kinase activity,type III phosphoinositide 3-kinase activity,Vps34p,1-phosphatidylinositol 3-kinase regulator activity,phosphatidylinositol 3-kinase, class I, regulator activity,protein domain-specific binding,down regulation of cell-cell adhesion,down-regulation of cell-cell adhesion,downregulation of cell-cell adhesion,inhibition of cell-cell adhesion,activation of cell migration,stimulation of cell migration,up regulation of cell migration,upregulation of cell migration,up-regulation of cell migration,ubiquitin ligase binding,response to E2 stimulus,GO:0010237,response to amino acid,phosphoinositide 3-kinase binding,PI3K binding,regulation of phosphoinositide 3-kinase activity,insulin receptor substrate [protein] binding,IRS [protein] binding,IRS binding,GO:0017036,activation of myoblast differentiation,stimulation of myoblast differentiation,up regulation of myoblast differentiation,upregulation of myoblast differentiation,up-regulation of myoblast differentiation,activation of anti-apoptosis,stimulation of anti-apoptosis,up regulation of anti-apoptosis,up-regulation of anti-apoptosis,upregulation of anti-apoptosis,down regulation of blood pressure,downregulation of blood pressure,down-regulation of blood pressure,inhibition of blood pressure,down regulation of proteolysis,downregulation of proteolysis,down-regulation of proteolysis,inhibition of proteolysis,negative regulation of peptidolysis,IGF receptor signaling pathway,IGF receptor signalling pathway,down regulation of smooth muscle cell proliferation,downregulation of smooth muscle cell proliferation,down-regulation of smooth muscle cell proliferation,inhibition of smooth muscle cell proliferation,negative regulation of SMC proliferation,phosphorylated protein binding,response to 3',5' cAMP,response to 3',5'-cAMP,response to adenosine 3',5'-cyclophosphate,response to cyclic AMP,HER3 receptor binding,Neu/ErbB-2 receptor activity,insulin receptor ligand,GO:0005067,IGF receptor binding,insulin-like growth factor,insulin-like growth factor receptor ligand,1-phosphatidylinositol-4-phosphate kinase, class IA complex,class IA PI3K complex,GO:0035030,phosphoinositide 3-kinase complex, class IA,EGF receptor signaling pathway,EGF receptor signalling pathway,EGFR signaling pathway,epidermal growth factor receptor signalling pathway,daf-2 receptor signaling pathway,insulin receptor signalling pathway,FGF receptor signaling pathway,FGF receptor signalling pathway,FGFR signaling pathway,fibroblast growth factor receptor signalling pathway,phosphoinositide 3-kinase cascade,PI 3-kinase cascade,PI3K cascade,activation of glucose import,positive regulation of glucose uptake,stimulation of glucose import,up regulation of glucose import,upregulation of glucose import,up-regulation of glucose import,inositol phospholipid-mediated signaling,phosphatidylinositol-mediated signalling,phosphoinositide-mediated signaling,phosphoinositide-mediated signalling,blood coagulation, platelet activation,T cell co-stimulation,T lymphocyte costimulation,T-cell costimulation,T-cell co-stimulation,T-lymphocyte costimulation,phosphoinositide 3-kinase regulator activity,PI3K regulator activity,insulin receptor substrate [protein] binding,IRS [protein] binding,IRS binding,interaction with another species,interspecies interaction,interspecies interaction with other organisms,GO:0046837,phosphatidylinositol phosphate biosynthetic process,phosphatidylinositol phosphate phosphorylation,phosphoinositide phosphorylation,PIP biosynthesis,PtdInsP biosynthesis,IGF receptor signaling pathway,IGF receptor signalling pathway,nerve growth factor receptor signalling pathway,NGF receptor signaling pathway,NGF receptor signalling pathway,T lymphocyte receptor signaling pathway,T lymphocyte receptor signalling pathway,T-cell receptor signaling pathway,T-cell receptor signalling pathway,TCR signaling pathway,T-lymphocyte receptor signaling pathway,T-lymphocyte receptor signalling pathway,immune cell migration,immune cell trafficking,leucocyte migration,leucocyte trafficking,leukocyte trafficking,cellular response to growth hormone,GH receptor signaling pathway,growth hormone receptor signalling pathway,positive regulation of establishment of protein localisation in plasma membrane,HER3 receptor binding,Neu/ErbB-2 receptor activity,insulin receptor ligand,GO:0005067,IGF receptor binding,insulin-like growth factor,insulin-like growth factor receptor ligand,1-phosphatidylinositol-4-phosphate kinase, class IA complex,class IA PI3K complex,GO:0035030,phosphoinositide 3-kinase complex, class IA,daf-2 receptor signaling pathway,insulin receptor signalling pathway,activation of glucose import,positive regulation of glucose uptake,stimulation of glucose import,up regulation of glucose import,upregulation of glucose import,up-regulation of glucose import,phosphoinositide 3-kinase regulator activity,PI3K regulator activity,insulin receptor substrate [protein] binding,IRS [protein] binding,IRS binding,GO:0046837,phosphatidylinositol phosphate biosynthetic process,phosphatidylinositol phosphate phosphorylation,phosphoinositide phosphorylation,PIP biosynthesis,PtdInsP biosynthesis,IGF receptor signaling pathway,IGF receptor signalling pathway,positive regulation of establishment of protein localisation in plasma membrane,down regulation of cell-matrix adhesion,down-regulation of cell-matrix adhesion,downregulation of cell-matrix adhesion,inhibition of cell-matrix adhesion,HER3 receptor binding,Neu/ErbB-2 receptor activity,insulin receptor ligand,GO:0005067,IGF receptor binding,insulin-like growth factor,insulin-like growth factor receptor ligand,1-phosphatidylinositol-4-phosphate kinase, class IA complex,class IA PI3K complex,GO:0035030,phosphoinositide 3-kinase complex, class IA,protein amino acid phosphorylation,daf-2 receptor signaling pathway,insulin receptor signalling pathway,1-phosphatidylinositol 3-kinase activity,ATP:1-phosphatidyl-1D-myo-inositol 3-phosphotransferase activity,GO:0004429,phosphatidylinositol 3-kinase activity, class I,phosphatidylinositol 3-kinase activity, class II,phosphatidylinositol 3-kinase activity, class III,phosphatidylinositol 3-kinase, class I, catalyst activity,PI3K,PI3-kinase activity,PtdIns-3-kinase activity,type I phosphatidylinositol kinase activity,type III phosphoinositide 3-kinase activity,Vps34p,B cell development,B lymphocyte differentiation,B-cell differentiation,B-lymphocyte differentiation,GO:0042115,activation of cell migration,stimulation of cell migration,up regulation of cell migration,upregulation of cell migration,up-regulation of cell migration,phosphoinositide 3-kinase regulator activity,PI3K regulator activity,down regulation of apoptosis,downregulation of apoptosis,down-regulation of apoptosis,inhibition of apoptosis,insulin receptor substrate [protein] binding,IRS [protein] binding,IRS binding,down regulation of osteoclast differentiation,downregulation of osteoclast differentiation,down-regulation of osteoclast differentiation,inhibition of osteoclast differentiation,IGF receptor signaling pathway,IGF receptor signalling pathway
UniprotAccessions :
Q63787,P23727,P27986,P26450
Gene :
PIK3R1,PIK3R1,Pik3r1,Pik3r1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5295, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=282307, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=18708, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=25513
EntityFormats :
S/N
UNSPSC :
41116161
ProductForm :
Tissue Culture Supernatant - liquid
PriceGBP :
295
PriceEUR :
414
PriceUSD :
414 USD
PriceCHF :
451.26
PriceSEK :
4351
PriceNOK :
4434
PriceDKK :
3088
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.